Background: The clinical effectiveness of hypertonic saline (HS) in individuals with cystic fibrosis (CF) can be compromised by adverse effects. The objective of this study was to examine the efficacy of hyaluronic acid (HA) in mitigating these negative occurrences.
Methods: A comprehensive review of the literature was carried out using three electronic databases: Medline, Cochrane Central, and Embase.